This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Chinese Academy of Sciences, Shanghaitech University. Active years: 2026.
Company Filing History:
1 out of 3,341 
1 out of 87 Years Active: 2026
Title: Fen Nie - Innovator in Aza-Ergoline Derivatives
Introduction
Fen Nie is a prominent inventor based in Shanghai, China. She has made significant contributions to the field of medicinal chemistry, particularly through her work on aza-ergoline derivatives. Her innovative approach has led to advancements in the understanding and application of these compounds.
Latest Patents
Fen Nie holds a patent for an aza-ergoline derivative and its preparation method, as well as its application. The patent describes a derivative that exhibits a structure as shown in formula (I). This aza-ergoline derivative demonstrates good affinity, agonistic activity, or selectivity to the dopamine D2 receptor. This discovery has potential implications in the treatment of various neurological conditions.
Career Highlights
Throughout her career, Fen Nie has been associated with prestigious institutions such as ShanghaiTech University and the Chinese Academy of Sciences. Her work in these organizations has allowed her to explore innovative solutions in her field. She has been recognized for her contributions to research and development in medicinal chemistry.
Collaborations
Fen Nie has collaborated with notable colleagues, including Jianjun Cheng and Sheng Wang. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in research.
Conclusion
Fen Nie's work on aza-ergoline derivatives showcases her innovative spirit and dedication to advancing medicinal chemistry. Her contributions have the potential to impact the field significantly, paving the way for future research and applications.